Xanthogranulomatous pyelonephritis (XPN) is an unusual and severe form of chronic inflammatory lesion of the kidney, characterised by the destruction of the renal parenchyma and the presence of multinucleated giant cells and lipid-laden macrophages, inflammatory infiltration and intensive renal fibrosis. There are a few cases in the literature which describe the disease in children. The pathomechanism of XPN is poorly understood. Renal obstruction with concomitant urinary tract infection is the most commonly associated pathological finding. The process is typically unilateral and may be focal or diffuse. In both cases, the perirenal infiltration is possible and can be mistaken for common renal neoplasm or inflammatory process. The symptoms are non-specific. Diagnostic imaging techniques with clinical suspicion have enabled XPN to be diagnosed and differentiated from malignancy with a high degree of confidence. Computed tomography (CT) is the mainstay of diagnostic imaging. The definitive diagnosis of XPN is based on pathological assessment after nephrectomy. We review and illustrate the clinical, radiological, surgical and pathological characteristics of XPN in children. All cases shown are surgically and histopathologically proven.
• XPN can present different clinical manifestations.
• CT is the mainstay of diagnostic imaging in XPN.
• Focal type of XPN should be included in the differential diagnosis of children with a renal mass.
• There are no clear guidelines on the management of XPN.
• Conservative and surgical treatments should be considered for each individual case.
• Histopathological examination confirms the diagnosis and excludes other benign and malign diseases.
Xanthogranulomatous pyelonephritis (XPN) is an unusual, atypical and severe form of chronic inflammatory lesion of the kidney, characterised by the destruction of the renal parenchyma and the presence of multinucleated giant cells and lipid-laden macrophages, as well as inflammatory infiltration and intensive renal fibrosis.
XPN is predominantly a disease of adults. In children it is diagnosed sporadically and is extremely rare in infants. The age of onset varies (21 days to 16 years), although 60–75% of cases have been diagnosed before 5 years of age . It affects boys and girls equally, and it is slightly more common in the left kidney. The pathomechanism of XPN is poorly understood. Some factors have been implicated, chronic urinary obstruction, ineffectively treated chronic infection by Proteus spp., Escherichia coli, Pseudomonas spp. and Klebsiella spp., lipid metabolism disorders and altered immune response .
Congenital urinary tract malformations are highly linked with development of XPN in children (vesico–ureteral reflux, ureteropelvic junction obstruction, extrophia vesical).
Obstruction due to renal calculi has been reported in 38–83% of cases and 31–50% of the calculi have been of the staghorn variety .
Since the youngest patient described was a baby boy aged 21 days , other factors have also been implicated in the aetiology and include a lymphatic obstruction, malnutrition, arterial insufficiency, venous occlusion and haemorrhage, and necrosis of pericaliceal fat .
Two forms of XPN have been described: a diffuse form (which occurs in about 75% or 90% of cases) [5, 6] and a focal (or pseudo-tumoural) form, which is less frequent and more commonly described in children.
The diffuse process has characteristic imaging features. The involved kidney enlarges but maintains its reniform shape; it shows nephrolithiasis, hydronephrosis, and loss and replacement of the normal corticomedullary junction by yellow masses extending to the renal pelvis and perirenal fat.
The focal form disease is confined to a renal segment or one pole of a duplex system, and the most common location is the lower pole of the kidney .
The perirenal infiltration is possible in both types and can be mistaken for common renal neoplasm (Wilms’ tumour, clear cell carcinoma) or inflammatory process (renal or perirenal abscess, renal tuberculosis, focal or diffuse nephritis, sarcoidosis or Wegener granulomatosis disease).
The treatment of the diffuse type usually requires a total nephrectomy with or without antibiotic therapy. The prognosis after surgery is excellent, and no recurrence of XPN in the healthy contralateral kidney has yet been reported. However, routine follow-up, including clinical examination, ultrasonography (US), blood count and urine examination is recommended to monitor the recurrence of stone disease in the contralateral unit and the development of urinary tract infection.
The less common segmental type can be cured by partial nephrectomy or by first-line antibiotic therapy, with no recurrence reported in published studies . The main problem is to confirm this diagnosis and exclude malign diseases. It is essential—in the presence of intrarenal mass—to perform biopsies for appropriate surgical management of focal XPN in order to avoid unnecessary total nephrectomy.
The radiological diagnosis of XPN cannot be carried out on the basis of a single test. Radiological features of US and computed tomography (CT) in combination with clinical suspicion must enable a diagnosis. Magnetic resonance imaging (MRI) is used most frequently. A Tc-99m DTPA (diethylene-triamine-penta-acetate) renal scan demonstrates non-function of the affected kidney.
The definitive diagnosis is based on pathological assessment after nephrectomy, which shows areas of parenchymal destruction and necrosis, as well as interstitial fibrosis and chronic inflammatory infiltrate composed of plasma cells, lymphocytes and numerous lipid-laden macrophages.
We review and illustrate the clinical, radiological, surgical and pathological characteristics of XPN in children. All cases shown are surgically and histopathologically proven.
The onset of the illness is usually subacute or chronic. The clinical features and laboratory findings of XPN resemble those of chronic pyelonephritis.
The symptoms are non-specific; the most common presenting sing of focal XPN is loin or flank pain, intermittent fever of unknown origin associated with anorexia, asthenia, a palpable flank or abdominal mass, and malaise with weight loss. Acute fever and flank tenderness are most common in the diffuse forms. Urinary symptoms such as dysuria are uncommon.
Laboratory results show a microcytic anaemia, an elevated erythrocyte sedimentation rate, leucocytosis, thrombocytosis and increased C-reactive protein in most patients.
Urinalysis may reveal pyuria, haematuria or proteinuria.
Radiological findings diagnose and classify XPN into three stages depending on the extension of the inflammation, namely: stage I (nephric XPN), stage II (perinephric XPN) and stage III (paranephric XPN) [10, 11].
Focal XPN is a disease limited to a renal segment or one pole of a duplex system. US shows a localised hypoechoic mass, frequently without a stone obstructing the calyx (Fig. 1) [5, 12]. The kidney appears otherwise normal. CT demonstrates a well-defined localised intrarenal mass with water-like attenuation. There may also be a rim enhancement attributed to granulation tissue or compressed renal parenchyma. Perirenal extension may exist (Fig. 2). These findings are virtually impossible to differentiate from renal abscess (Fig. 3) or neoplasm (Fig. 4) [13, 14]. There are few data about MRI findings in the focal form. The lesion is isointense with the renal parenchyma on T1-weighted imaging and has slightly low signal intensity on T2-weighted. These findings suggest a fluid with a very high protein content. MRI, and especially the T2 sequences, are useful with the absence of hyperintensity in the differentiation of XPN from tumoural masses. The different signal intensity of the solid component of XPN on T1-weighted images, compared to the renal parenchyma, depends on the amount of xanthoma cells occurring in the lesion [1, 3, 15, 16].
In diffuse XPN, US shows an enlargement of the entire kidney although the reniform shape is maintained (Fig. 5). Multiple hypoechoic areas represent calyceal dilatation and parenchymal destruction. Depending on the extension, perinephritic fluid collection is present (Fig. 6). Fatty infiltration can be seen invading and expanding the kidney (Fig. 7). Lithiasis appears in up to 83% of XPN cases, calculus being from one-third to half staghorn (Figs. 8 and 9) .
CT is the cornerstone of diagnostic imaging for diffuse XPN. The typical CT appearance is of global renal enlargement with multiple low-attenuation rounded areas replacing the renal parenchyma (Fig. 10). These represent either dilated calyces or focal areas of destruction filled with pus or debris and have been described as the “bear paw sign”. On CT after intravenous contrast, the walls of these cavities demonstrate enhancement, due to vascular granulation tissue (Fig. 11). The renal pelvis is usually contracted around a central calculus, although calculus can be multiple and diffuse inside different calyces (Fig. 12). The presence of lipomatous component helps to diagnose XPN (Fig. 13). CT identifies extension of extrarenal disease to involve the perinephric and paranephric spaces, the posterior abdominal wall or psoas muscle (Fig. 14) [18, 19]. Adenopathies are frequently present. In adults, a study reports that 87% of patients who had undergone CT were well diagnosed preoperatively . However, less common CT features can be seen: absence of calculi, important pelvic dilatation or renal atrophy (Fig. 15) [14, 21].
MRI findings in diffuse XPN are variable, probably because the signal intensity of the solid component of XPN on T1-weighted images depends on the amount of xanthoma cells involved in the granulomatous process. The signal intensity on T2-weighted images is isointense compared to the normal kidney. The content of the cavities is hypointense on T1-weighted images and hyperintense on T2-weighted with fluid-fluid levels. Perirenal infiltration is hypointense on both T1 and T2 sequences due to the presence of thick fibrinous exudate. Extensive sinus replacement lipomatosis is easily recognised with MRI. After the administration of a contrast medium (gadolinium-DTPA), the rim enhancements of the borders of the cavities and delineates perirenal inflammatory extension with bright and thickening of perirenal fascia. This finding is important for surgical planning, and MRI visualises it better than CT. Progressively, MRI will replace CT as the method of choice for the diagnosis of XPN .
The management of XPN differs between focal and diffuse form.
Owing to the difficult differential diagnosis of focal XPN with renal tumours (Wilms’s tumour), it is often necessary to perform either image-guided biopsy or intraoperative biopsy to avoid unnecessary nephrectomy [1, 24, 25]. In focal XPN, treatment modes are partial nephrectomy, drainage of XPN abscess, or broad-spectrum antibiotic. There have been case reports of successful medical management of focal XPN , but it is unusual because of uncertain prognostic.
Clinical and imaging features are suggestive of diffuse XPN and biopsy is not required before nephrectomy , which remains as the standard of care for diffuse disease. Nevertheless, the indication for nephrectomy is not always straightforward. There is no published evidence suggesting whether differential function can be used to guide the treatment of diffuse XPN. Differential function of near 20% is used as a recommendation for nephrectomy . Up to 80.5% of the affected kidneys are non-functioning .
Surgery of diffuse XPN can be difficult as a result of inflammatory processes extending beyond the kidney (Fig. 17), and although laparoscopic procedure is the first option , sometimes it must be changed to lumbotomy or anterolateral transperitoneal approach. Cutaneous fistula, bowel fistula and delayed wound healing have been reported as complications; consequently, in order to improve the surgical results, it is recommended to drain the perirenal and/or renal abscess prior to surgery [3, 28].
The management of bilateral XPN is difficult due to the risk of permanent renal dysfunction. Partial nephrectomy is advocated but more recently conservative management with antibiotic therapy has been proposed [1, 9].
The diffuse type of XPN is associated with a worse prognosis compared to the focal type, although no recurrence of XPN in the healthy contralateral kidney has been reported.
The final diagnosis of XPN is histopathological.
The initial description of the pathological features of XPN was published in 1916 by Schlagenhaufer , but the first paediatric cases were not described until 1963 by Avnet et al.  and Friedenberg and Spjut .
After nephrectomy by diffuse XPN, gross examination shows an enlarged kidney with a thickened capsule (Fig. 18) and a marked loss of renal parenchymal replaced by yellow fatty nodules with or without central necrosis. The renal pelvis and calyces are dilated and filled with stones, debris or pus (Fig. 19). Sometimes, a structural anomaly such as a narrow ureteropelvic junction may be present (Fig. 20) .
Diffuse and focal XPN microscopic findings include a mixed acute and chronic inflammatory cell infiltrate with giant cells and lipid-laden macrophages (foam cells) (Fig. 21). Discrete lymphoid follicles, granulation tissue, intensive fibrosis and hyalinised glomeruli sclerosis may identify [5, 11, 16, 32].
XPN in children is a rare condition and preoperative diagnosis, especially of the focal type, remains challenging. Increasingly sensitive radiological methods, such as US, CT and MRI in combination with clinical suspicion enable the diagnosis. There are no clear guidelines on the management of XPN, thus conservative and surgical treatments should be considered for each individual case. The final diagnosis is histopathological.
Shah K, Parikh M, Gharia P, Modi PR (2012) Xanthogranulomatous pyelonephritis—mimicking renal mass in 5-month-old child. Urology 79:1360–1362
Iumanne S, Shoo A, Akoko L, Scanlan P (2016) Case report: xanthogranulomutous pyelonephritis presenting as “Wilms’ tumour”. BMC Urol 16:36
Bingöl-Kologlu M, Ciftçi AO, Senocak ME et al (2002) Xanthogranulomatous pyelonephritis in children: diagnostic and therapeutic aspects. Eur J Pediatr Surg 12:42–48
Youngson GG, Gray ES (1990) Neonatal xanthogranulomatous pyelonephritis. Br J Urol 65:541–542
Rao AG, Eberts PT (2011) Xanthogranulomatous pyelonephritis: an uncommon pediatric renal mass. Pediatr Radiol 41:671–672
Chlif M, Chakroun M, Ben Rhouma S et al (2016) Xanthogranulomatous pyelonephritis presenting as a pseudotumour. Can Urol Assoc J 10:36–40
Macpherson RI, Leithiser RE (1987) Serendipitous diagnosis of childhood xanthogranulomatous pyelonephritis in a child with osteomyelitis. Pediatr Radiol 17:159–161
El Yacoubi S, Ziouziou I, Zizi M et al (2014) Piélonéphrite xanthogranulomatous bilatérale focale: à propos d’un case. Can Urol Assoc J 8:E666–E669
Tsai KH, Lai MY, Shen SH (2008) Bilateral xanthogranulomatous pyelonephritis. J Clin Med Assoc 71:310–314
Malek RS, Elder JS (1978) Xanthogranulomatous pyelonephritis: a critical analysis of 26 cases and of the literature. J Urol 119:589–593
Hendrickson R, Lutfiyya W, Karrer F et al (2006) Xanthogranulomatous pyelonephritis. J Pediatr Surg 41:15–17
Hayes W, Hartman D, Sesterbenn I (1991) Xanthogranulomatous pyelonephritis. Radiographics 11:485–498
Kim JC (2001) US and CT findings of xanthogranulomatous pyelonephritis. Clin Imaging 25:118–121
Loffroy R, Guiu B, Watfa J et al (2007) Xanthogranulomatous pyelonephritis in adults: clinical and radiological findings in diffuse and focal forms. Clin Radiol 62:884–890
Cakmakci H, Tasdelen N, Obuz F et al (2002) Pediatric focal xanthogranulomatous pyelonephritis: dynamic contrast-enhanced MRI findings. J Clin Imaging 26:183–186
Hugoson C, Ahmed S, Sackey K et al (1994) Focal xanthogranulomatous pyelonephritis in a young child. Pediatr Radiol 24:213–215
Gupta S, Araya C, Dharnidharta V (2010) Xanthogranulomatous pyelonephritis in pediatric patients: case report and review of literature. J Pediatr Urol 6:355–358
Zafaranloo S, Gerard PS, Bryk D (1990) Xanthogranulomatous pyelonephritis in children: analysis by diagnostic modalities. Urol Radiol 12:18–21
Segovis C, Dyer R (2015) The “bear paw” sign. Abdom Imaging 40:2049–2050
Eastham J, Ahlering T, Skinner E (1994) Xanthogranulomatous pyelonephritis: clinical findings and surgical considerations. Urology 43:295–299
Das C, Ahmad Z, Sharma S et al (2014) Multimodality imaging of renal inflammatory lesions. World J Radiol 6:865–873
Verswijvel G, Oyen R, Van Poppel H et al (2000) Xanthogranulomatous pyelonephritis: MRI findings in the diffuse and the focal type. Eur J Radiol 10:586–589
Cousins C, Somers J, Broderick N et al (1994) Xanthogranulomatous pyelonephritis in childhood: ultrasound and CT diagnosis. Pediatr Radiol 24:210–212
Muro Velilla D, Sangüesa Nebot C, Picó Aliaga S (2009) Pielonefritis xantogranulomatosa focal en niño. Radiología Abdom 6:15
Rodó J, Martin ME, Salarich J (1996) Xanthogranulomatous pyelonephritis in children: conservative management. Eur Urol 30:498–501
Brown PS, Dodson M, Weintrub PS (1996) Xanthogranulomatous pyelonephritis: report of nonsurgical management of a case and review of the literature. Clin Infect Dis 22:308–314
Brown J, Chamberlain J, Roth C (2013) The role of laparoscopic nephrectomy in pediatric xanthogranulomatous pyelonephritis: a case report. Case Rep Urol 2013:598950
Kapoor R, Vijan V, Singh K et al (2006) Is laparoscopic nephrectomy the preferred approach in xanthogranulomatous pyelonephritis? Urology 68:952–955
Schlagenhaufer F (1916) Uber eigentumliche staphylomykosen der nieven ind des pararenalen bindegewebes. Frankfurt Z Pathol 19:139–148
Avnet NL, Roberts TW, Goldberg HR (1963) Tumefactive xanthogranulomatous pyelonephritis. Am J Roentgenol Radium Ther Nucl Med 90:89–96
Friedenberg MJ, Spjut HJ (1963) Xanthogranulomatous pyelonephritis. Am J Roentgenol Radium Ther Nucl Med 90:97–108
Berenguer A, Pilar C, Smit M et al (2012) Xanthogranulomatous pyelonephritis presenting as a pseudotumour in a 5-year-old boy. BMJ Case Reports 12:2012
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sangüesa Nebot, C., Picó Aliaga, S., Serrano Durbá, A. et al. Xantogranulomatous pyeloneprhritis in children. Insights Imaging 9, 643–651 (2018). https://doi.org/10.1007/s13244-018-0631-4
- Computed tomography